Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Asia Pacific MedTech (BVI) Ltd
 2. Date of Event Requiring Statement (Month/Day/Year)
04/19/2017		 3. Issuer Name and Ticker or Trading Symbol
Sorrento Therapeutics, Inc. [SRNE]
(Last)
(First)
(Middle)
C/O OFFSHORE INCORPORATIONS LIMITED, OFFSHORE INCORPORATIONS CENTRE POBOX 957		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

ROAD TOWN, TORTOLA, D8 VG110		 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 9,301,801
D (1)
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrants (Right to Buy) 06/07/2016 06/07/2019 Common Stock 261,438 $ 8.5 D (1)  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Asia Pacific MedTech (BVI) Ltd
C/O OFFSHORE INCORPORATIONS LIMITED
OFFSHORE INCORPORATIONS CENTRE POBOX 957
ROAD TOWN, TORTOLA, D8 VG110		     X    
Gu Nana
C/O OFFSHORE INCORPORATIONS LIMITED
OFFSHORE INCORPORATIONS CENTRE POBOX 957
ROAD TOWN, TORTOLA, D8 VG1110		     X    

Signatures

/s/ Nana Gu, Asia Pacific MedTech (BVI) Limited-Director 05/03/2017
**Signature of Reporting Person Date
/s/ Nana Gu 05/03/2017
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This Form 3 is being filed by Asia Pacific MedTech (BVI) Limited as the direct beneficial owner of the shares of Common Stock and Common Stock Warrants. Nana Gu is the indirect beneficial owner of the shares of Common Stock and Common Stock Warrants in her capacity as the sole director and sole shareholder of Asia Pacific MedTech (BVI) Limited.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.